National Cancer Institute Director Ned Sharpless will serve as acting FDA Commissioner when Scott Gottlieb steps down from the agency next month, Health and Human Services Secretary Alex Azar said Tuesday.
div > div.group > p:first-child"> The administration is currently searching for a permanent replacement, Azar told the House Energy & Commerce Health Subcommittee Hearing. Gottlieb announced his resignation last week.
Gottlieb's resignation took Washington and the health-care community by surprise. Some wondered what would happen to some of the policies Gottlieb advanced, like a crackdown on teen vaping.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Altria shares hit after National Cancer Institute director named acting head of the FDAAltria investors don't seem to like the prospects for the cigarette maker under the new acting FDA commissioner.
Weiterlesen »
National Cancer Institute Director Ned Sharpless named acting FDA commissionerNational Cancer Institute Director Ned Sharpless will serve as acting FDA Commissioner when Scott Gottlieb steps down from the agency next month, Health and Human Services Secretary Alex Azar said Tuesday.
Weiterlesen »
Norman Sharpless, National Cancer Institute chief, appointed acting FDA commissionerNational Cancer Institute Director Norman “Ned” Sharpless will become acting commissioner of the Food and Drug Administration, succeeding Scott Gottlieb who is leaving next month, Health and Human Services Secretary Alex Azar told Congress Tuesday.
Weiterlesen »
Trump proposal would slash total cancer funding while boosting pediatric cancer researchThe administration proposed a $50 million increase in funding for pediatric cancer research. But the budget also included a large overall cut for the National Cancer Institute, upsetting researchers.
Weiterlesen »
'Jeopardy' Host Alex Trebek Revealed He Has Stage 4 Pancreatic Cancer'I plan to beat the low survival rate statistics for this disease,' Trebek said, asking fans for their prayers.
Weiterlesen »
FDA approves first immunotherapy regimen for breast cancerThe US Food and Drug Administration granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday. The drug, Genentech's Tecentriq, was approved for use in combination with Abraxane chemotherapy for patients who have a type of advanced triple negative breast cancer.
Weiterlesen »
Roche's Tecentriq notches win in breast cancer with U.S. approvalRoche won U.S. approval on Friday of its immunotherapy Tecentriq to treat a sign...
Weiterlesen »
Often diagnosed too late, hope for pancreatic cancer may be on the horizonEfforts to improve early detection and more targeted treatment approaches could offer some hope, experts say.
Weiterlesen »
The African Childhood Cancer Specialists Lost On Ethiopian Airlines Flight 302Among the 32 Kenyans onboard Ethiopian Airlines flight 302 were three women on their way back home after a conference focused on improving the lives of children with cancer in Africa.
Weiterlesen »